Laparoscopic nephrectomy for renal cell carcinoma

被引：17

作者：

Kim I.Y. ^{[1
]}

Schulam P.G. ^{[1
]}

机构：

[1] Scott Department of Urology, Baylor College of Medicine, 6560 Fannin, Suite 2100, Houston, 77030, TX

来源：

Current Urology Reports | 2001年 / 2卷 / 1期

关键词：

Laparoscopic Nephrectomy; Laparoscopic Partial Nephrectomy; Partial Nephrectomy; Radical Nephrectomy; Renal Cell Carcinoma;

D O I：

10.1007/s11934-001-0024-x

中图分类号：

学科分类号：

摘要：

Since the first reported case of laparoscopic nephrectomy by Clayman et al. [1] in 1991, laparoscopy is gaining acceptance as a viable alternative to open surgery for renal cell carcinoma. The benefits of laparoscopy include improved quality of life and lower incidence of perioperative morbidity. The perceived risks of laparoscopic nephrectomy for renal cell carcinoma include port-site metastasis, increased operative time, and the concern for inadequate surgical resection. The preliminary data concerning laparoscopy in renal cell carcinoma, however, indicate that rates of tumor recurrence are equivalent to open surgery while resulting in better cosmesis, decreased level of perioperative analgesic use, and decreased length of time to full convalescence. © 2001, Current Science Inc.

引用

页码：40 / 45

页数：5

共 64 条

[1]

Clayman R.V., Kavoussi L.R., Soper N.J., Et al., Laparoscopic nephrectomy: initial report, J Urol, 146, pp. 278-282, (1991)

[2]

Greenlee R.T., Murray T., Bolden S., Wingo P.A., Cancer statistics 2000, CA Cancer J Clin, 50, pp. 7-33, (2000)

[3]

Meloni A.M., Bridge J., Sandberg A.A., Reviews on chromosome studies in urological tumors. I. Renal tumors, J Urol, 148, pp. 253-265, (1992)

[4]

Pathak S., Strong L.C., Ferrell R.E., Trindade A., Familial renal cell carcinoma with a 3:11 chromosome translocation limited to tumor cells, Science, 217, pp. 939-941, (1982)

[5]

Cohen A.J., Li F.P., Berg S., Marchetto D.J., Et al., Hereditary renalcell carcinoma associated with a chromosomal translocation, N Engl J Med, 301, pp. 592-595, (1979)

[6]

Latif F., Tory K., Gnarra J., Et al., Identification of the von Hippel-Lindau disease tumor suppressor gene, Science, 260, pp. 1317-1320, (1993)

[7]

Mydlo J.H., Zajac J., Macchia R.J., Conditioned media from renal cell carcinoma cell line demonstrates the presence of basic fibroblastic growth factor, J Urol, 150, pp. 997-1001, (1993)

[8]

Stadler W.M., Vogelzang N.J., Human renal cancer carcinogenesis. A review of recent laboratory advances, Ann Oncol, 4, pp. 451-462, (1993)

[9]

Sion-Vardi N., Kaneti J., Segal-Abramson J., Et al., Gonadotropinreleasing hormone specific binding sites in normal and malignant renal tissues, J Urol, 148, pp. 1568-1570, (1992)

[10]

Rosenberg S.A., Yang J.C., Topalian S.L., Et al., Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2, JAMA, 271, pp. 907-913, (1994)

← 1 2 3 4 5 6 7 →